Citrin Cooperman Adds Browne Consulting Group in Massachusetts
•February 10, 2026
0
Why It Matters
The purchase deepens Citrin’s specialization in a high‑growth, regulation‑intensive sector, positioning the firm to capture more lucrative biotech advisory work. It also signals continued consolidation among accounting firms targeting niche industries.
Key Takeaways
- •Citrin acquires Browne Consulting, adding 60 professionals
- •Strengthens Boston presence in life sciences advisory
- •Expands service offering for biotech startups, pre‑seed to Series A
- •Marks Citrin’s first M&A deal of 2026
- •Adds to firm’s 30+ acquisitions since 2019
Pulse Analysis
The accounting industry has entered a phase of strategic consolidation, with firms seeking to augment niche capabilities that align with high‑margin markets. Life sciences and biotech, driven by robust venture capital inflows and complex regulatory landscapes, have become prime targets for advisory services. By integrating Browne Consulting, Citrin Cooperman taps into a specialized talent pool that can navigate the financial, operational, and human‑resource challenges unique to early‑stage biotech firms, thereby enhancing its value proposition beyond traditional audit work.
Citrin’s Boston expansion is more than geographic; it represents a deliberate move to embed itself within the innovation hub of the Northeast. The combined entity can now offer end‑to‑end solutions—from operational accounting for pre‑seed startups to strategic finance for Series A and beyond—leveraging Browne’s deep sector knowledge and Citrin’s national network. Clients benefit from a unified platform that delivers industry‑specific insights, regulatory compliance guidance, and scalable advisory support as they transition from research to commercialization.
Looking ahead, the deal underscores a broader trend of accounting firms pursuing sector‑focused growth through M&A. As biotech continues to attract funding and regulatory scrutiny intensifies, firms that can provide tailored, high‑touch services will command premium fees. Citrin’s track record of over 30 acquisitions since 2019 positions it to further consolidate expertise, potentially sparking additional partnerships in adjacent high‑growth verticals such as health‑tech and med‑device. This strategic momentum is likely to reshape competitive dynamics, rewarding firms that blend deep industry knowledge with expansive advisory capabilities.
Citrin Cooperman Adds Browne Consulting Group in Massachusetts
Top 20 accounting firm Citrin Cooperman has made its first M&A deal of 2026, announcing Tuesday that it has acquired Browne Consulting Group, a Boston‑based firm that provides accounting and other advisory services to the life sciences and biotech sectors.
Financial terms of the deal weren’t disclosed. Browne Consulting joins Citrin Cooperman with approximately 60 professionals.
Citrin Cooperman said this acquisition strengthens its presence in Boston and enhances its ability to serve clients throughout the life sciences and biotech industries nationally.
Alan Badey
“We are thrilled to welcome Browne into the Citrin Cooperman family. Our organizations share a deep commitment to client service, a collaborative culture, and a passion for delivering strategic, industry‑specific insights. Browne’s deep expertise in life sciences and biotech consulting will accelerate our growth in this high‑impact sector. Together, we’ll deliver even greater value to our clients as they navigate the complexities of innovation, regulation, and growth in the life sciences ecosystem,”
— Alan Badey, CEO of Citrin Cooperman Advisors, statement on Feb. 10.
Founded in 2016 and with offices in Cambridge, MA, and Boston, Browne Consulting specializes in providing operational accounting, strategic finance, and tactical HR support for life‑science companies, including venture‑capital‑backed startups—from pre‑seed to Series A and beyond, the firm says in its LinkedIn profile.
“We couldn’t be more excited to join forces with Citrin Cooperman. Our cultural synergies and shared commitment to integrity, innovation, and client success have been evident since our early discussions,”
— Warren Browne, founder and CEO of Browne Consulting, statement.
“Citrin Cooperman’s reach and resources, paired with our deep specialized experience in life sciences and biotech, creates a powerful platform to help our clients solve their most complex challenges.”
Allan Koltin, CEO of Koltin Consulting Group, who advised both firms on the transaction, added, “I congratulate both organizations on structuring a deal that not only makes strategic sense but also respects and enhances the unique cultural DNA of each firm. Their collective expertise in navigating life sciences opportunities will be a formidable offering for clients seeking trusted partners in a rapidly evolving space.”
Citrin Cooperman has been one of the most active accounting firms making M&A deals in recent years, completing more than 30 acquisitions since 2019, many of them after receiving private‑equity backing in 2022.
With more than 3,600 professionals, Citrin Cooperman is an independent member firm of the Moore North America Inc. Association, which is itself a regional member of Moore Global Network Ltd., one of the world’s leading accountancy and advisory networks with over 37,000 professionals in 563 offices across 116 countries.
0
Comments
Want to join the conversation?
Loading comments...